Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Tight control of blood glucose in type 1 diabetes delays onset of macrovascular and microvascular diabetic complications; however, glucose levels need to be closely monitored to prevent hypoglycaemia. We aimed to assess whether a factory-calibrated, sensor-based, flash glucose-monitoring system compared with self-monitored glucose testing reduced exposure to hypoglycaemia in patients with type 1 diabetes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet

Title: Lancet (London, England)

Publisher: Elsevier BV

ISSN (Electronic): 1474-547X

ISSN (Print): 0140-6736

Publication date (Electronic): Nov 05 2016

Volume: 388

Issue: 10057

Affiliations

[1 ] Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institute, Stockholm, Sweden. Electronic address: jan.bolinder@ki.se.

[2 ] Clinidiabet, Corrida, Gijón, Spain.

[3 ] Department of Internal Medicine, Medical Center Haaglanden, The Hague, Netherlands.

[4 ] Centre for Diabetology Hamburg Bergedorf, Hamburg, Germany.

[5 ] Department of Internal Medicine, Wehrle-Diakonissen Hospital Salzburg, Salzburg, Austria; Paracelsus Medical University, Salzburg, Austria.

Article

Publisher Item ID: S0140-6736(16)31535-5

DOI: 10.1016/S0140-6736(16)31535-5

PubMed ID: 27634581

SO-VID: 1f49afea-495b-49e1-a2f8-a16440e70d9d

History

Data availability:

Comments

Comment on this article

Cited by 368

See all cited by

- Version 1